Redalpine is a thesis-driven venture capital firm with deep expertise in software and science, investing in key areas they believe will have the biggest impact on the world.

Redalpine

Medical Devices Venture is a holding company that develops a portfolio of investments in Med Tech start-ups. The aim is to combine the expertise of researchers in hospital and university settings with industrialization and commercialization capabilities.

Medical Devices Venture

Seed: your accelerator AG provides support for startups at any stage of development to promote growth. Seed is involved in connecting startups with resources and expertise tailored to their individual needs.

seed: your accelerator AG

redalpine is the Swiss venture capital firm that empowers GameChangers. Founded in 2006, redalpine brings together financial investment, operational expertise, and a vast international network to help ambitious entrepreneurs transform their vision into a reality. 

With over €1bn in assets under management and a disciplined, sector-agnostic investment strategy, the firm has backed some of Europe’s most disruptive companies, including N26, Taxfix, Inkitt, 9fin, Carvolution, Zenjob, vivenu, and Umiami. redalpine has over 95 companies in its portfolio and invests Europe-wide from its offices in Zurich and Berlin. 

redalpine

How Mistral AI is changing the game in LLM ⚡

Large Language Models (LLMs) have become a cornerstone of contemporary AI and foundational modeling, with Generative AI alone presenting a $137bn market opportunity this year. Previously, Europe lagged behind American tech heavyweights - until now.

Mistral AI has quickly emerged as a European champion of innovation and an international LLM powerhouse, marking a turning point in the global AI landscape. With their open-source modeling, the French-founded company prioritizes a faster, more customizable, and accessible product for users.

#EmpoweringGameChangers - Already demonstrating remarkable growth, and backed by substantial funding and strategic partnerships with industry giants such as Microsoft, NVIDIA, and Salesforce, we were delighted to invest in Mistral’s recent €600M Series B round via our multi-stage Summit Fund.

We look forward to supporting founders Arthur Mensch, Timothee Lacroix, and Guillaume Lample in this exciting growth phase, transforming the face of generative AI in Europe and beyond!

Read more about why we invested here: https://lnkd.in/dbqG9rwj 

#AI #TechInnovation #VC #FutureOfAI

#empoweringGameChangers 🚀

👋 In case you missed it: Our June newsletter just went out featuring what we (and our portfolio companies) have gotten up to lately!

📰 In this edition, we announce new investments from our multi-stage Summit Fund in Mistral AI and Klarna, introduce new team members, and share updates from Taxfix, Proxima Fusion, Aktiia, Sanity Group, Genialis, and Jodel.

👓 Read more here: https://lnkd.in/etBY4_uN

If you enjoyed this newsletter, feel free to sign up to our mailing list: https://lnkd.in/dX6XcMwd

🇬🇧 Taxfix has arrived in the UK!

Exciting news for UK taxpayers: Taxfix has acquired TaxScouts, the market leader in accountant-assisted digital tax filing.

This strategic move marks Taxfix’s entry into the UK market, where over 12 million taxpayers do self-assessment filings, yet nearly half struggle with the process. This presents a significant growth opportunity in Taxfix’s mission to simplify tax filing for everyone.

🚀 #empoweringGameChangers - Since our lead investment in Taxfix’s Series A round in 2018, the company has become the European leader in digital tax filing, helping German clients get an average refund of over €1000. Peter continues to advise the team as they accelerate the company's growth through internationalization, expanded tax offerings, and advanced AI capabilities.

Congratulations to Martin Ott, Lino Teuteberg, Mathis Büchi Ginzbourg, and the entire Taxfix team on the achievement!

Read more about the news in this article by Cate Lawrence on Tech.eu: https://lnkd.in/eJ4-YcHi

One step closer to clean, abundant, and affordable energy in Europe! 🚀 

Proxima Fusion just signed a framework agreement with the Paul Scherrer Institute (PSI), initiating a long-term collaboration to fast-track the commercialization of fusion energy.

Several Proxima team members, led by Proxima’s Co-Founder Martin Kubie, will move to Switzerland Innovation Park Innovaare to develop high-temperature superconducting magnet technology. In partnership with PSI, Europe’s largest research center for natural and engineering sciences, the project aims to advance applications in both fusion energy and particle physics research.

#empoweringGameChangers - Since Harald and Gianmarco spearheaded our lead investment in Proxima’s seed round earlier this year, the company has continued to gain momentum as the team works to tackle Europe’s growing energy challenge In fact, Proxima was recently recognized by the World Economic Forum as a 2024 Technology Pioneer.

We are proud to support game-changing startups that are helping shape a better world. Congratulations to Lucio Milanese, Francesco Sciortino, Jorrit Lion, Jonathan Schilling, and Martin Kubie 👏

Read more here: https://lnkd.in/ee5dV8cz

#VC #RenewableEnergy #energytransition

🌿 High times ahead! Sanity Group has secured an additional €17 million in growth capital from the Jupiter Fund of Organigram Inc 💥 

The investment will be instrumental in further expanding Sanity's European market presence and accelerating its product development. 

🚀 #empoweringGameChangers: Since we first invested in Sanity's Series A round in 2020, the company has continued to go from strength to strength. Today, Sanity owns around 10% of the German medical cannabis market, and they are currently participating in a recreational cannabis distribution pilot project in the Swiss canton of Basel-Landschaft.

Oliver Pabst continues to actively support Sanity with team development and go-to-market, helping to bolster the company’s growth and innovation. Congratulations to Finn Age Hänsel and team Sanity for achieving this milestone, we look forward to reaching even higher peaks together!

For more details, check out the press release 👉 https://lnkd.in/dAZQVBaC

#Cannabis #medtech #GrowthCapital #MedicalCannabis #HealthcareInnovation

We’re excited to attend the Pension Symposium at Messe Zürich!

On Day 2 Rafael will be joining a dynamic panel discussion on “Private Markets and Impact,” alongside industry leaders Peter Begler(Fidelity International), Raphaela Schmid (SUSI Partners), Werner Kerschl (IFM Investors), Anja Nieberding (Goldman Sachs), and Peer Rosenberg (Neuberger Berman). They will provide insights into the challenges facing Swiss institutional investors in private markets and explore the future role of impact investments.

We are proud to co-sponsor this event dedicated to examining current pension systems, discussing innovative ways to future-proof them, and pioneering new solutions for a better future by unlocking the economic potential of innovations.

🗓 Date: June 6
 🕰 Time: 10:45–11:30
 📍 Location: Anlagepanel Bachtelplatz

👋 Come visit us at Stand 36 and meet Michael, Hiroshi, Noah and Rafael. We look forward to saying hello!

#PensionSymposium #PrivateMarkets #ImpactInvesting #SustainableInvesting #FutureOfFinance

Metric
Company Name	Redalpine	Medical Devices Venture	seed: your accelerator AG
Symbol
MSH ID	COM:REDALPINE	COM:MEDICALDEVICESVENTURE	COM:SEED-ACCELERATOR
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Healthcare & Health Services	Commercial & Professional Services
Industry	Venture Capital	Medical Devices	Business Consulting
Country	CH	FR	DE
Stage
Employee Count	46
Website	redalpine.com	medicaldevicesventure.com	seed-accelerator.com
LinkedIn	redalpine	medical-devices-venture
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	4.15K
Web Traffic Growth	-0.03
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

REDA

COM:REDALPINE

Redalpine

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue